Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
48
STXE Quote, Financials, Valuation and Earnings
Last price:
$27.90
Seasonality move
:
4.92%
Day range:
$27.55 - $27.93
52-week range:
$26.46 - $31.90
Dividend yield:
3.19%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
20.2K
Avg. volume:
24.5K
1-year change:
3.81%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for STXE
--
Most recent earnings per share
--
Missed by --
(Dec 23/2024)
Consensus Estimate
--
(Dec 23/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
STXE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|
Strive Emerging Markets Ex-China ETF Earnings Questions
-
How Much did Strive Emerging Markets Ex-China ETF Generate in Revenue Last Quarter?
Strive Emerging Markets Ex-China ETF reported -- worth of top line sales in its most recent quarter.
-
Did Strive Emerging Markets Ex-China ETF Beat Earnings Last Quarter?
Strive Emerging Markets Ex-China ETF announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Strive Emerging Markets Ex-China ETF Profitable?
Strive Emerging Markets Ex-China ETF reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Strive Emerging Markets Ex-China ETF EPS Next Year?
Strive Emerging Markets Ex-China ETF's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.
-
When is Strive Emerging Markets Ex-China ETF's Earnings Date?
Currently, Strive Emerging Markets Ex-China ETF has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
